1. Mandal, S.C. and M. Mandal, 2010. Current status and future prospects of new drug delivery system. Pharmatimes, 42: 13-16.
   Direct Link  |  
2. Mandal, S.C. and M. Mandal, 2009. Evolution of regulation for conducting clinical trials in India. Pharnatimes, 41: 19-23.
3. Mandal, M. and S.C. Mandal, 2008. Improving access to Opoid for pain relief. Pharma Times, 40: 15-18.
4. Ponnusankar, S., P. Venkatesh, M. Venkatesh, S.C. Mandal and Pulok K. Mukherjee, 2007. Herbal drugs require pharmacovigilance study-Need and reality. Pharma Rev., 6: 113-120.
   Direct Link  |  
5. Mandal, S.C. and M. Mandal, 2007. The role of hospital pharmacists in the new global scenario: A paradigm shift. Pharmatimes, 39: 21-24.
6. Das, S.C., M. Mandal and S.C. Mandal, 2007. A critical study on availability and price variation between different brands: Impact on access of medicines. IJPS, 69: 160-163.
   Direct Link  |  
7. Mandal, S.C., 2005. Resurgence of pharma industry in West Bengal: The future story. Pharma Pulse, 11: 17-18.
8. Mandal, S.C. and M. Mandal, 2005. Antibiotic resistance-The tragedy of commons. Pharmatimes, 37: 41-42.
9. Ghosh, A., A. Hazra and S.C. Mandal, 2004. New drugs in India over the past 15 years: Analysis of trends. Natl. Med. J. India, 17: 10-16.
   PubMed  |  
10. Mandal, S.C., 2002. Concept of essential drugs and rational use of drugs. Pharmatimes, 34: 9-13.